Report Detail

Pharma & Healthcare Global Esomeprazole Capsule Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4685094
  • |
  • 12 March, 2026
  • |
  • Global
  • |
  • 123 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Esomeprazole Capsule market size was valued at US$ 2727 million in 2025 and is forecast to a readjusted size of US$ 4041 million by 2032 with a CAGR of 5.8% during review period.
In 2025, global Esomeprazole Capsule production reached approximately 6309.52 million units, with an average global market price of around US$0.42 per capsule.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of esomeprazole capsules was approximately 8412.69 million units.
Esomeprazole Capsules are oral proton pump inhibitor formulations used to suppress gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme in gastric parietal cells. They are widely prescribed for the treatment of gastroesophageal reflux disease, peptic ulcer disease, erosive esophagitis, and Helicobacter pylori eradication therapy.
The industrial chain of Esomeprazole Capsules includes upstream active pharmaceutical ingredients, excipients, capsule shells, and packaging materials. The midstream focuses on formulation development, granulation, encapsulation, coating, and quality control. Downstream applications cover hospital prescriptions, retail pharmacies, and outpatient treatment settings, supported by regulatory compliance, distribution, and pharmacovigilance services.
The esomeprazole capsule market is supported by stable demand for acid-related disorder treatments. As a widely used proton pump inhibitor, esomeprazole remains a first-line therapy for GERD and peptic ulcer disease. Growth is driven by aging populations, increasing gastrointestinal disease prevalence, and continued use of generic formulations. Price competition is intense in mature markets, while volume growth remains stable. Overall, the market is expected to grow moderately with demand centered on large-volume, cost-effective generic production.
This report is a detailed and comprehensive analysis for global Esomeprazole Capsule market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Esomeprazole Capsule market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Esomeprazole Capsule
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Esomeprazole Capsule market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha, Saval Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Esomeprazole Capsule market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Short-Term Use
Long-Term Use
Market segment by Release Profile
Immediate-Release Capsule
Enteric-Coated Capsule
Modified-Release Capsule
Market segment by Market Type
Originator Drug
Generic Drug
Hospital Use Capsule
Market segment by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Major players covered
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Esomeprazole Capsule product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Esomeprazole Capsule, with price, sales quantity, revenue, and global market share of Esomeprazole Capsule from 2021 to 2026.
Chapter 3, the Esomeprazole Capsule competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Esomeprazole Capsule breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Esomeprazole Capsule market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Esomeprazole Capsule.
Chapter 14 and 15, to describe Esomeprazole Capsule sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Esomeprazole Capsule Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Short-Term Use
    • 1.3.3 Long-Term Use
  • 1.4 Market Analysis by Release Profile
    • 1.4.1 Overview: Global Esomeprazole Capsule Consumption Value by Release Profile: 2021 Versus 2025 Versus 2032
    • 1.4.2 Immediate-Release Capsule
    • 1.4.3 Enteric-Coated Capsule
    • 1.4.4 Modified-Release Capsule
  • 1.5 Market Analysis by Market Type
    • 1.5.1 Overview: Global Esomeprazole Capsule Consumption Value by Market Type: 2021 Versus 2025 Versus 2032
    • 1.5.2 Originator Drug
    • 1.5.3 Generic Drug
    • 1.5.4 Hospital Use Capsule
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Esomeprazole Capsule Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Gastroesophageal Reflux Disease
    • 1.6.3 Duodenal Ulcers
    • 1.6.4 Others
  • 1.7 Global Esomeprazole Capsule Market Size & Forecast
    • 1.7.1 Global Esomeprazole Capsule Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Esomeprazole Capsule Sales Quantity (2021-2032)
    • 1.7.3 Global Esomeprazole Capsule Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca AB
    • 2.1.1 AstraZeneca AB Details
    • 2.1.2 AstraZeneca AB Major Business
    • 2.1.3 AstraZeneca AB Esomeprazole Capsule Product and Services
    • 2.1.4 AstraZeneca AB Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca AB Recent Developments/Updates
  • 2.2 Sandoz
    • 2.2.1 Sandoz Details
    • 2.2.2 Sandoz Major Business
    • 2.2.3 Sandoz Esomeprazole Capsule Product and Services
    • 2.2.4 Sandoz Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sandoz Recent Developments/Updates
  • 2.3 Actavis
    • 2.3.1 Actavis Details
    • 2.3.2 Actavis Major Business
    • 2.3.3 Actavis Esomeprazole Capsule Product and Services
    • 2.3.4 Actavis Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Actavis Recent Developments/Updates
  • 2.4 Teva.
    • 2.4.1 Teva. Details
    • 2.4.2 Teva. Major Business
    • 2.4.3 Teva. Esomeprazole Capsule Product and Services
    • 2.4.4 Teva. Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva. Recent Developments/Updates
  • 2.5 Mylan
    • 2.5.1 Mylan Details
    • 2.5.2 Mylan Major Business
    • 2.5.3 Mylan Esomeprazole Capsule Product and Services
    • 2.5.4 Mylan Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mylan Recent Developments/Updates
  • 2.6 KernPharm
    • 2.6.1 KernPharm Details
    • 2.6.2 KernPharm Major Business
    • 2.6.3 KernPharm Esomeprazole Capsule Product and Services
    • 2.6.4 KernPharm Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 KernPharm Recent Developments/Updates
  • 2.7 Garmish Pharmaceuticals
    • 2.7.1 Garmish Pharmaceuticals Details
    • 2.7.2 Garmish Pharmaceuticals Major Business
    • 2.7.3 Garmish Pharmaceuticals Esomeprazole Capsule Product and Services
    • 2.7.4 Garmish Pharmaceuticals Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Garmish Pharmaceuticals Recent Developments/Updates
  • 2.8 Sanofi
    • 2.8.1 Sanofi Details
    • 2.8.2 Sanofi Major Business
    • 2.8.3 Sanofi Esomeprazole Capsule Product and Services
    • 2.8.4 Sanofi Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sanofi Recent Developments/Updates
  • 2.9 Mepha
    • 2.9.1 Mepha Details
    • 2.9.2 Mepha Major Business
    • 2.9.3 Mepha Esomeprazole Capsule Product and Services
    • 2.9.4 Mepha Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mepha Recent Developments/Updates
  • 2.10 Saval Pharmaceutical
    • 2.10.1 Saval Pharmaceutical Details
    • 2.10.2 Saval Pharmaceutical Major Business
    • 2.10.3 Saval Pharmaceutical Esomeprazole Capsule Product and Services
    • 2.10.4 Saval Pharmaceutical Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Saval Pharmaceutical Recent Developments/Updates
  • 2.11 Stada
    • 2.11.1 Stada Details
    • 2.11.2 Stada Major Business
    • 2.11.3 Stada Esomeprazole Capsule Product and Services
    • 2.11.4 Stada Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Stada Recent Developments/Updates
  • 2.12 Blaskov
    • 2.12.1 Blaskov Details
    • 2.12.2 Blaskov Major Business
    • 2.12.3 Blaskov Esomeprazole Capsule Product and Services
    • 2.12.4 Blaskov Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Blaskov Recent Developments/Updates
  • 2.13 CQ Lummy
    • 2.13.1 CQ Lummy Details
    • 2.13.2 CQ Lummy Major Business
    • 2.13.3 CQ Lummy Esomeprazole Capsule Product and Services
    • 2.13.4 CQ Lummy Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 CQ Lummy Recent Developments/Updates
  • 2.14 Novartis
    • 2.14.1 Novartis Details
    • 2.14.2 Novartis Major Business
    • 2.14.3 Novartis Esomeprazole Capsule Product and Services
    • 2.14.4 Novartis Esomeprazole Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Novartis Recent Developments/Updates

3 Competitive Environment: Esomeprazole Capsule by Manufacturer

  • 3.1 Global Esomeprazole Capsule Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Esomeprazole Capsule Revenue by Manufacturer (2021-2026)
  • 3.3 Global Esomeprazole Capsule Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Esomeprazole Capsule by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Esomeprazole Capsule Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Esomeprazole Capsule Manufacturer Market Share in 2025
  • 3.5 Esomeprazole Capsule Market: Overall Company Footprint Analysis
    • 3.5.1 Esomeprazole Capsule Market: Region Footprint
    • 3.5.2 Esomeprazole Capsule Market: Company Product Type Footprint
    • 3.5.3 Esomeprazole Capsule Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Esomeprazole Capsule Market Size by Region
    • 4.1.1 Global Esomeprazole Capsule Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Esomeprazole Capsule Consumption Value by Region (2021-2032)
    • 4.1.3 Global Esomeprazole Capsule Average Price by Region (2021-2032)
  • 4.2 North America Esomeprazole Capsule Consumption Value (2021-2032)
  • 4.3 Europe Esomeprazole Capsule Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Esomeprazole Capsule Consumption Value (2021-2032)
  • 4.5 South America Esomeprazole Capsule Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Esomeprazole Capsule Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 5.2 Global Esomeprazole Capsule Consumption Value by Type (2021-2032)
  • 5.3 Global Esomeprazole Capsule Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 6.2 Global Esomeprazole Capsule Consumption Value by Application (2021-2032)
  • 6.3 Global Esomeprazole Capsule Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 7.2 North America Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 7.3 North America Esomeprazole Capsule Market Size by Country
    • 7.3.1 North America Esomeprazole Capsule Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Esomeprazole Capsule Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 8.2 Europe Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 8.3 Europe Esomeprazole Capsule Market Size by Country
    • 8.3.1 Europe Esomeprazole Capsule Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Esomeprazole Capsule Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Esomeprazole Capsule Market Size by Region
    • 9.3.1 Asia-Pacific Esomeprazole Capsule Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Esomeprazole Capsule Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 10.2 South America Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 10.3 South America Esomeprazole Capsule Market Size by Country
    • 10.3.1 South America Esomeprazole Capsule Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Esomeprazole Capsule Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Esomeprazole Capsule Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Esomeprazole Capsule Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Esomeprazole Capsule Market Size by Country
    • 11.3.1 Middle East & Africa Esomeprazole Capsule Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Esomeprazole Capsule Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Esomeprazole Capsule Market Drivers
  • 12.2 Esomeprazole Capsule Market Restraints
  • 12.3 Esomeprazole Capsule Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Esomeprazole Capsule and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Esomeprazole Capsule
  • 13.3 Esomeprazole Capsule Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Esomeprazole Capsule Typical Distributors
  • 14.3 Esomeprazole Capsule Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Esomeprazole Capsule. Industry analysis & Market Report on Esomeprazole Capsule is a syndicated market report, published as Global Esomeprazole Capsule Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Esomeprazole Capsule market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report